1985
DOI: 10.1056/nejm198509263131301
|View full text |Cite
|
Sign up to set email alerts
|

Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings

Abstract: Marrow transplantation has generally been limited to patients with a sibling who is genotypically identical for HLA. In a study of the acceptable limits of HLA incompatibility, 105 consecutive patients with hematologic cancers who received marrow grafts from haploidentical donors (study group) were compared with 728 similar patients concurrently receiving grafts from HLA genotypically identical siblings (control group). The unshared haplotypes differed variably: 12 were phenotypically but not genotypically ide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
305
2
4

Year Published

1990
1990
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 777 publications
(322 citation statements)
references
References 15 publications
7
305
2
4
Order By: Relevance
“…Two main risk factors are linked to the occurrence of aGVHD: the T cell content of the graft and the HLA disparities between donor and recipient. With respect to HLA disparities, the increased risk of aGVHD linked to HLA-A, -B, -DR mismatching between donor and recipient is well established (3)(4)(5)(6)(7)(8), in contrast HLA-DP incompatibility does not seem to be a risk factor for aGVHD (for review see references 9 and 10). Accordingly, it was proposed that HLA-DP determinants might not function as transplantation antigens in the same way as HLA-A, -B, or -DR (10).…”
Section: Introductionmentioning
confidence: 99%
“…Two main risk factors are linked to the occurrence of aGVHD: the T cell content of the graft and the HLA disparities between donor and recipient. With respect to HLA disparities, the increased risk of aGVHD linked to HLA-A, -B, -DR mismatching between donor and recipient is well established (3)(4)(5)(6)(7)(8), in contrast HLA-DP incompatibility does not seem to be a risk factor for aGVHD (for review see references 9 and 10). Accordingly, it was proposed that HLA-DP determinants might not function as transplantation antigens in the same way as HLA-A, -B, or -DR (10).…”
Section: Introductionmentioning
confidence: 99%
“…The patients enrolled in this study died from pulmonary edema, fever, fluid retention or kidney failure. This syndrome is known as engraftment syndrome, a diagnosis confirmed in another study by Beatty et al [14].…”
Section: Discussionmentioning
confidence: 63%
“…The search for a donor, therefore, starts among the patient's biological siblings, where there is a 25 percent chance of each sibling being HLA-matched. At the beginning of the HSCT era it was predominantly HLA-matched siblings who were used as donors (Beatty et al, 1985;Gluckman, 2012). However, since it is not always possible to find a suitable donor among siblings, registries of unrelated donors have been established.…”
Section: Prognosismentioning
confidence: 99%